Journal article
Authors list: Lambova, Sevdalina; Mueller-Ladner, Ulf
Publication year: 2011
Pages: 5-6
Journal: Nature Reviews Rheumatology
Volume number: 7
Issue number: 1
ISSN: 1759-4790
eISSN: 1759-4804
DOI Link: https://doi.org/10.1038/nrrheum.2010.207
Publisher: Nature Research
Abstract:
Digital ulcers in patients with systemic sclerosis (SSc) can cause considerable disability; however, clinical trials addressing the treatment and prevention of digital ulcers in SSc are rare. A study has evaluated the potential benefit of the endothelin receptor antagonist bosentan in the treatment of SSc-related digital ulcers.
Citation Styles
Harvard Citation style: Lambova, S. and Mueller-Ladner, U. (2011) CONNECTIVE TISSUE DISEASES Treatment of digital ulcers in systemic sclerosis, Nature Reviews Rheumatology, 7(1), pp. 5-6. https://doi.org/10.1038/nrrheum.2010.207
APA Citation style: Lambova, S., & Mueller-Ladner, U. (2011). CONNECTIVE TISSUE DISEASES Treatment of digital ulcers in systemic sclerosis. Nature Reviews Rheumatology. 7(1), 5-6. https://doi.org/10.1038/nrrheum.2010.207
Keywords
BOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; EULAR SCLERODERMA TRIALS; Iloprost; RAYNAUDS-PHENOMENON
